A benchmarking and evidence-informed gap analysis of the hemodialysis care provision in Iran Authors: Leila Zhianfar, Haidar Nadrian, Abdolreza Shaghaghi Published: 2024 ABSTRACT BackgroundPatients with end stage renal disease (ESRD) are increasing worldwide. This is especially paramount in low and middle income countries in which ESRD patients are struggling to access specialist services e.g. hemodialysis (HD). Benchmarking analysis of the offered healthcare packages in several countries and comparison of the utilized alternative healthcare models for ESRD patients may be auspicious for institutional capacity-building in the existing healthcare facilities. Main aim of this study was to perform a benchmarking and evidence-informed gap analysis of the ESRD care provision in Iran and recognize the gaps that cause diversification in care quality for ESRD patients that hinder efforts for care quality improvement in the Iranian National Healthcare System.MethodsDimensions of the Australian Anglicare Southern Queensland Clinical and Care Governance Framework (ASQCGF) were utilized as corner stones of a comprehensive clinical care plan that is essential in responding to HD patients’ needs in Iran. An extensive literature search was performed at the next stage to recognize the gold standard core elements. The ascertained components were assigned to the five separate dimensions of the ASQCGF and a preliminary draft (comprehensive package of care for HD patients) was prepared. A checklist was developed at a later stage which was sent to a panel of expert consisting professional healthcare providers in nephrology and hemodialysis wards for their opinions. A gap analysis was conducted to evaluate current care processes of the Iranian HD patients align with the elements of the gold standard framework.ResultsThe identified deficits were classified in five areas in accord with the elements of ASQCGF as follow: A) supply of resources, medical devices and equipment support B) recruitment and endorsement of clinics and general work force C) infection prevention and controlling procedures D) care effectiveness monitoring and quality improvement E) provision of safe environment for both HD patients and hospitals’ staff.ConclusionsThe study findings revealed considerable gaps in providing quality HD services to the Iranian HD patients that herald their therapeutic unmet needs and the shift that is needed to narrow down the widening organizational failure which fuels the current disenchantment among the both healthcare providers and HD patients. Introduction Spreading sedentary lifestyle and population aging and the subsequent increase in the global prevalence of obesity, hypertension, diabetes and chronic kidney disease (CKD) posed an extra burden on the healthcare delivery systems (HCDs) across the world [1, 2]. This is specially paramount in low and middle income countries (LMICs) which already face with surge of demands for healthcare to meet unequivocal and implied clients' needs [3]. Healthcare institutions in many countries are under pressure from the beneficiaries, patients and social groups to provide high quality services where an inherent shortage of logistic, finance and skilled workforce hamper any quality improvement efforts [1–3]. Therefore, strengthening of existing structures is required to ensure their adequate performance and optimized utilization of available resources. Complying with internationally agreed set of standard operating procedures (SOPs) is a crucial first step toward helping healthcare providers (HCPs) for successful task scheduling and execution. The priority is not properly addressed nor secured in many healthcare settings in LMICs [3–5]. The result is a widening gap between the healthcare demands for high-quality services and de facto performance standards. Patients with end stage renal disease (ESRD) are increasing worldwide, with a growing burden on HCDs [4]. ESRD patients in many LMICs are struggling to access specialist services e.g. hemodialysis (HD), peritoneal dialysis and kidney transplantation but fairly a good proportion of them fail to receive their most needed life-saving care and eventually die prematurely from the consequent complications [5]. Those patients that have fortune to access their needed care for ESRD often complain of the low or deteriorating quality of the obtained care [6]. Unstable care quality and cross-center diversity of provided care to ESRD patients is well documented in the literature [7]. The reported healthcare variability in centers that provide specialist services to ESRD patients may stem from limitations of fiscal and administrative sources or simply from failure in organizational mindfulness or performance [7, 8]. Without having of a robust and globally agreed comprehensive plan of care for ESRD patients or in the case of its existence neglecting the SOPs precisely may also cause diverse care quality among the centers [9, 10]. Thus, obervation of disparate care qualities will be unavoidable even across centers in defined geographical regions and inside countries. The International Society of Nephrology (ISN) in cooperation with a number of guideline developers, suggested appropriate set of care standards for HD patients with taking into account meagre availability of human and financial resources in many parts of the world [9]. Benchmarking analysis of the offered healthcare packages in several countries and comparison of the utilized alternative healthcare models for ESRD patients may be auspicious for institutional capacity-building in the existing healthcare facilities and minimize the current discordance in the quality of provided care [10]. Three important reasons were suggested for implementation of a benchmarking analysis in HCDs i.e. to control health care costs, for risk management and boosting care quality, and to meet patients’ unanswered needs [11]. Iran as a typical LMIC faces important challenges in providing quality care for ESRD patients [12]. There are several reports of drastically variable care quality in the HD centers with considerable impacts on the patients’ quality of life (QOL) [12–14]. One of the reason for such a rampant organizational turmoil is not using of a substantive and up-to-date care protocol for meeting the ESRD patients’ needs. Main aim of this study was to perform a benchmarking and evidence-informed gap analysis of the ESRD care provision in Iran and recognize the gaps that cause diversification in care quality for ESRD patients. The paucity hinder efforts for care quality improvement (CQI) in the Iranian National Healthcare System (INHS). This study’s findings could shed light on major steps that is needed be taken towards a well-functioning HCDs in the country. Methodology Dimensions of the Australian Anglicare Southern Queensland Clinical and Care Governance Framework (ASQCGF) [15] were utilized as corner stones of a comprehensive clinical care plan (Fig. 1) for consolidation of best-practice components of a healthcare package that is essential in responding to HD patients’ needs in Iran. An extensive literature search was performed on several databases including PubMed, Scopus, Embase, ScienceDirect and also Google Scholar at the next stage from September 2020 up to April 2023 to recognize the gold standard core elements of an encompassing care protocol to cloak needs of the country’s HD patients in a tertiary care center.Fig. 1Dimensions of an exemplar best practice clinical and care governance framework (adapted from the Australian Anglicare Southern Queensland Clinical and Care Governance Framework (ASQCGF) [15] Dimensions of an exemplar best practice clinical and care governance framework (adapted from the Australian Anglicare Southern Queensland Clinical and Care Governance Framework (ASQCGF) [15] The ascertained components were assigned according to the five separate dimensions of the ASQCGF [15] and a preliminary draft of an exemplar comprehensive package of care for HD patients (CPC-HD) in responding to their diverse needs was prepared. A checklist was developed at a later stage consisting of the care elements listed in the preparatory framework which was sent to a panel of expert (two nephrologists and three experienced nurses working in the HD wards) seperately for their approval in the first place and also their opinions about de facto status of the HD wards they are working in the next step. The number of experts were assumed to be satisfactory and representative of the country wide HCPs who work in the HD wards since, all the teching hospitals in Iran are working under the supervision of the Ministry of Health and Medical Education (MOHME) and almost face common institutional level logistic and operational constraints. The solicted experts verified inclusiveness of the provided checklist in terms of the listed care components and therefore, no further amendment was performed on the preliminary draft. The informants were asked to give their responses in a three Likert-type scale options (yes/no/somewhat) to indicate factual state of care provision to the HD patients in their wards. Based on the given feedbacks a gap analysis (GA) was conducted to evaluate the extent to which current care provision processes to the Iranian HD patients align with the elements of the suggested gold standard framework (Fig. 2). The analysis was performed by the researchers individually and any disagreement was resolved by consensus. The outlined National Accreditation Standards and Guidelines for Hospitals (NASGH) [16] were also examined in addition to the expert panel members’ feedbacks in conducting the GA to ensure legislative and regulatory inclusiveness of the wards’performance data.Fig. 2Flow diagram of the steps used to perform a gap analysis of hemodialysis (HD) care provision in the Iranian hospitals Flow diagram of the steps used to perform a gap analysis of hemodialysis (HD) care provision in the Iranian hospitals This gap analysis process was implemented based on the collected data in one of the stages of a larger study that had been endorsed by the institutional level Medical Ethics Board of Trustees (MEBoT) affiliated to the Tabriz University of Medical Sciences (approval number: IRCT20171213037859N1). Partial findings of the conducted large-scale study were reported elsewhere [17, 18]. Results The approached panelists’ feedbacks and findings from detailed assessment of the NASGH [16] were used to compare the list of procedures and already provided or assumed to be necessary care components to HD patients in Iran with elements of the devised CPC-HD. Thus, gaps in terms of important care segments and main insufficiencies of the HD wards in the Iranian hospitals were identified. The identified deficits were classified in five areas in accord with the elements of ASQCGF [15] as follow: A) supply of resources, medical devices and equipment support B) recruitment and endorsement of clinics and general work force C) infection prevention and controlling procedures D) monitoring of care effectiveness and quality improvement E) provision of safe environment for both HD patients and hospitals’ staff. Detailed list of shortages in these five categories of deficits in care provision for the Iranian HD patients was provided in Table 1. Table 1Gap analysis of the current care provision processes for the Iranian HD patients compared to elements of the devised comprehensive package of care for HD patients (CPC-HD)1. Patients' participation in therapeutic decisionsYes/No/Somewhat1. Making the decision to start dialysis jointly by the family and healthcare provider (HCP) about renal replacement therapy (RRT) and several options [17, 18]Yes2. Ultrasound scan or ultrasound before vascular access operation 6 months before starting HD [17]Yes3. Vascular access ways checking in order of preference: arteriovenous fistula (AVF), arterio-venous graft (AVG) and central venous catheter (CVC) [19]Yes4. Training of infection control measures before start of work in HD wards and its annual repetition (topics may include hand washing / taking care of vascular access and detecting signs of infection / administering recommended vaccines) [20]Yes5. Awareness of the risk of dialysis flow interruption, pressure alarm limits and direct observation through an educational program to both physicians and caregivers [21]Somewhat6. Encouraging and empowering patients to actively participate in self-care [17]Somewhat7. Continuous counseling and support of patients and their family members regarding optimal diet and fluid intake [17]Somewhat8. Referring patients to other sources of information and support such as online resources, pre-dialysis classes and peer support groups [17]Somewhat9. Availability of required medicines such as erythropoietin and sevelamer [22]Somewhat10. Appropriate laboratory support for monitoring the effectiveness of HD and early detection of anemia, nutritional status, and infection [22]Somewhat11. Assessment of patient's functional capacity, planned exercise and fall risk reduction strategies [22]No12. Access to exercise facilities with trained staff during dialysis sessions to improve HD patients' quality of life without contraindications [21]No13. Facilitating HD patients' commuting to wards, their economic and activities of daily living (ADL) support [22]Somewhat14. Connecting HD patients to different support networks [22]No15. Identifying those risk factors that may interfere with a successful kidney transplantation such as: non-compliance with treatment, severe mental illness, etc. [17]Somewhat16. Assessment of home hemodialysis possibility [18]No17. Awareness the risks of repeated home HD such as: complications of vascular access and accelerated reduction of residual kidney function [18]No18. Limitations of the HD wards in admitting patients based on the defined personnel and equipment capacity [23]No19. Possibility of financial assistance to low-income patients [23]Somewhat20. Possibility of ensuring access to regular dialysis treatments [23]Somewhat21. Possibility of being responsible against HD patients’ requests to change dialysis schedules in case of problems [23]Yes22. Possibility of timely presence of a physician at the patient's bedside in emergency situations and access to ambulance services [23]Somewhat23. Availability of counseling services for HD treatment, dietary recommendations and medication adherence [23]Yes24. Confidentiality of personal and medical information of HD patients and their accessibility only for designated employees [23]Yes25. Obtaining the patient's informed consent before starting hemodialysis treatment regarding: treatment method, side effects, cost of care, etc. [23]Yes26. Availability of patients’ bill of rights and explanation of their responsibilities, the HD wards' working days/hours timetable (generally six (6) days a week, including official holidays), facilitation of HD patients' transfer to other HD centers based on their request, continuity of care for patients who transfer to other HD centers, establishing a patient complaint system for considering suspected errors and having an official patirnts' informed consent form [23]Yes2. Risk Management and infection control measuresYes/No/Somewhat1. Presence of a strict guideline and its enforcement to prevent the risk of cross-infection among HD patients [20, 24]Somewhat2. Examining patients for HBsAg and anti-HCV before starting the first HD treatment or accepting a patient from another HD center [20] along with checking initial liver function tests [24]Yes3. If HBsAg is negative, retest every three months [20]Yes4. Vaccination of patients if they are HBsAg and HBs Ab negative (four doses sould be administered: zero (0), one (1), two (2) and six (6) months) / if anti HBs Ab < 100 mIU/ml; a booster dose is required [20]Yes5. Examination of anti-HBs Ab serum one to two (1–2) months after completing the vaccination period [20]Yes6. Re-immunization after primary vaccination in patients without anti-HBs Ab response (> 10 mIU/ml) including one to three doses (1–3) [20]Yes7. Examining patients with anti-HBs titer less than 10 every 6 months [24]Yes8. Receiving a course of hepatitis B vaccination according to the national immunization guidelines for non-immune cases of HD patients [22, 24]Yes9. The nurses of HBsAg positive patients should not take care of other patients in the same shift [20]Yes10. Annual screening for blood viruses for HBsAg-negative employees (if anti-HBs antibody is zero, do a full course of vaccination / if anti-HBs antibody is less than 10 mIU/ml a booster dose is required) [20, 24] and re-checking the annual anti-HBs titer [24]Yes11. Receiving HBV vaccine by all dialysis ward staff if there is no proof of previous immunity or previous vaccination [24]Yes12. Refrain to employ a non-immune staff against hepatitis B or those who failed to respond to hepatitis B vaccine for caring HBsAg positive patients [24]Yes13. Training all employees at risk of occupational exposure to blood about hand hygiene, correct use of protective equipments, routes of blood-borne viruses' transmission [20]Yes14. Use of masks and gowns by all nurses and assistants, especially when starting or stopping treatment or blood sampling [22, 24]Somewhat15. Wearing gloves when contacting the dialysis machine and changing it between patients, presence of hand washing and disinfection facilities in several parts of HD wards [22]Yes16. Using gloves, gowns and protective glasses and using a mask/face shield while working to prevent the risk of exposure to blood or other body fluids [24]Somewhat17. Hand hygiene and aseptic technique and its regular observance in HD centers by dialysis staff [24]Yes18. Disinfection of reusable equipment (if disinfection is not possible, such as sphygmomanometer cuff, these devices must be cleaned and dried) [24]Yes19. Allocation of physiological monitoring equipment such as thermometer, barometer and scales for use by each patient [24]No20. Frequent disinfection of touchable places in the patient's environment in HD ward [24]Yes21. Disposing of needles in a metal container (or resistant plastic containers) as safety box using non-contact technique [24]Yes22. Using disposable items and throwing them away after use [24]Yes23. Central venous catheter (CVC), arteriovenous fistula (AVF) and breathing care of all HD patients [23]Yes24. Immunization of HD patients for influenza, pneumococcus and COVID-19 vaccines in addition to hepatitis B vaccine [23]Except pneumococcal vaccinesSomewhat25. Screening of patients before starting HD treatment for viral infections transmitted by blood (hepatitis B, C and HIV) and monitoring according to the national guideline [23]Yes3. Safe Environment, equipments and related productsYes/No/Somewhat1. Sufficient space for the dialysis machine and bed/couch/chair (4.5 m2 to 10 m2 with access to cardiopulmonary resuscitation (CPR) equipment) [20, 22]Somewhat2. A separate room with machines, equipment, tools, disposable items for HBsAg positive patients [20, 22, 24]Yes3. A separate room or an isolated area with a fixed partition and dedicated dialysis machines for patients with active hepatitis C [20, 24] No4. A separate room with machines, equipment, tools, disposable items for HIV-positive patients [20, 24]No5. A separate room for water purification of the necessary size and equipment [20, 22, 23] with the schematic diagram of water purification system [23]Somewhat6. A dialysis filter reprocessing room in case of reuse of filters and re-storage of processed and sterilized filters with proper and efficient ventilation to reduce the risk of inhalation [20, 22]No7. A separate room with a separate filter reprocessing machine to reprocess the filters of hepatitis B and hepatitis C patients separately [12, 14]No8. Releasing of dialysis and reprocessing effluent to the closed general drainage system / not using formaldehyde in case of discharging the effluent to a septic tank and having sufficient capacity of the tank to manage the volume of effluent [20]Somewhat9. Access to a stable electrical source as well as oxygen and suction outlets in each ward [22]Yes10. A list of items in the CPR trolley and its review at regular intervals [23]Yes11. Management and monitoring of cold chain storage for medicinal products [23]YesEquipment 1. Ability to perform conventional HD (diffusion) and preferably convection treatment in HD devices [20, 22]Yes 2. Providing a reliable power source (to ensure returning blood from the arterial-venous lines to the body in case of a power cut) [20, 22]Yes 3. At least one backup device for every ten (10) HD machines [20]No 4. Disinfection of external surfaces of HD devices after each session [20, 22]Somewhat 5. Disinfection of the internal hydraulic circuit of HD machines after the last daily session [20, 22]Yes 6. Having Planned Preventive Maintenance (PPM) and technical safety check for all machines and documentation [20]Yes 7. Possibility of continuous renal replacement therapy (CRRT) in all wards as part of a comprehensive program of RRT [21]SomewhatDialysis consumables 1. Request of a valid quality certificate for all commercial dialysis solution [20, 22]Yes 2. Validation of filters used for HD treatment [20, 22]Yes 3.Request of a valid quality certificate for the arterial-venous sets that are used for HD treatment and taking all precautionary measures for prevention of their reuse [20, 22]Yes 4. Request of a valid quality approval for arterial-venous needles that are used during HD treatment [20, 22]Yes 5. Disposal of clinical waste according to the current instructions of the Ministry of Health and Medical Education (MOHME) [20] (refrigerated storage in case of daily collection at 4–6 degree of celsius and daily recording of the room temperature) [23]YesWater quality 1. Daily chlorine/chloramine test and hardness test every morning before starting HD treatment [20]No 2. Perform monthly tests for bacterial and endotoxin pollutions [20, 22]Yes 3. Production of dialysis water by reverse osmosis (RO) process [20]Yes 4. Six months test in an accredited laboratory to analyze and check chemical compounds of the water are used [20]Yes4. Workforce and human resources managementYes/No/Somewhat1. Assigning the role of dialysis department head to a nephrologist or a general physician with at least 200 h of formal training in HD treatment [20–22]Somewhat2. Recruit nurses/medical assistants with at least six (6) months of training and experience in the field of HD [20–22] with valid annual practicing certificate (APC) [23]Somewhat3. Recruit head-nurses with a basic degree in renal nursing and valid APC with at least two years of work experience in the HD department [23]Somewhat4. The presence of at least one nurse/medical assistant with at least six months training of HD treatment for every six HD patients [20]Somewhat5. The presence of at least one nurse/medical assistant trained in CPR techniques in each shift [20]Yes6. Performing HD according to the order of a nephrologist or a general physician with the necessary training under the supervision of a nephrologist [20]Yes7. HD treatment and care by a nurse or medical assistant with training and experience in the field of HD treatment and care [20]Yes8. Availability of trained technicians to repair HD machines [21, 22]No9. The presence of social workers and nutritionists in the HD ward [22]No10. Monitor all proceedings of prevention and infection control processes at the facility by a designated and trained nurse and document catheter-related bloodstream infections (CRBSIs), fistula infections, blood-borne viral and bacterial infections, and COVID-19 infections [23]Yes5. Care Effectiveness and monitoring of HD patients' improvementYes/No/Somewhat1. Start HD if uremic symptoms affect daily life, biochemical values, uncontrollable fluid overload or estimated glomerular filtration rate (eGFR) of about 5 to 7 ml/min/1.73 m2 [17, 18]Yes2. Recording each session and monitoring any complication during HD (nausea, vomiting and headache / hypotension or hypertension / pyrogenic reaction: shivering, convulsions, fever during dialysis / hemolysis / acute blood loss / air embolism / mental status change / signs and symptoms of first HD syndrome including: chest pain, anxiety, shortness of breath and back pain), vital signs during dialysis, vascular access [20] and informing the patient about all these risks before the start of treatment [18]Yes3. Staff training in dealing with emergencies during HD including: acute hypotension, blood loss, hemolysis, air embolism, dialysis membrane reactions, high fever, sepsis and cardiovascular emergencies and their management [21, 22]Yes4. Appropriate protocols to monitor complications such as: patency and infections in AVF and AVGs [22]Somewhat5. Blood tests should be done regularly at intervals of three months or moreYes6. Checking the adequacy of dialysis at least every three months (Kt/V more than 1.2 or urea reduction ratio (URR) more than 65%) [15, 19, 20]Yes7. Focus on preserving residual kidney function by emphasizing strategies to reduce the rate and frequency of hypotensive attacks during HD, applying slower ultrafiltration rates, encouraging a low-sodium diet, avoiding unnecessary use of nephrotoxic medicines (such as aminoglycosides and radiocontrast) and prevention of infection [22]Yes8. Evaluation of protein and energy status by nutritionists (prevalence of malnutrition problem is high in most HD patients due to insufficiency of HD, underlying inflammation and undiagnosed infections) [17, 22]No9. Having a quality improvement program for achieving objectives of the standard care, including management of high blood pressure, fluid overload, infections, and reporting physical findings [22]No10. Perform HD at least 12 h per week for most patients (3 times per week) with minimal residual function [18, 21]Yes11. Using filters with artificial or cellulose membranes to prevent blood pressure drop during HD with symptoms [25]Yes12. Using high-flux filters for patients with minimal residual function and removal of molecules such as microglobulin beta 2 [21, 25]Yes13. Considering the benefits of high-flux filters for the survival of diabetic patients, patients with HD history of more than 3.7 years and serum albumin less than 40 g/L [25]Yes14. Use of high-flux or low-flux filters (biocompatible) for intermittent HD [18]Yes15. Proposing hemodiafiltration as a treatment for resistant hypotensive patients in comparison to HD patients with good prognosis [21]No16. Washing HD lines and filters to lose minimal blood [21]Yes17. Fluid and volume control in HD patients through salt restriction, use of diuretics and antihypertensive medicines [22]Yes18. Starting erythropoietic stimulating agents to reach a hemoglobin level of 9 to 10 g/dL [22]Yes19. Treatment of mineral and bone disorders to reduce phosphorus serum level, diet counseling and prescription of medicines (such as Sevelamer with lower rate of mortality compared to calcium-based binders) to reduce phosphorus absorption from the gastrointestinal tract [22]Yes20. Parathyroid Hormone (PTH) lowering treatment with medicines: calcimimetics, calcitriol or vitamin D analogs [22]Yes21. Avoiding excessive ultrafiltration in case of fluid overload by using an additional schedule and adjusting the dialysis temperature [21]Yes22. Management of hyperkalemia through: reducing dialysis solution potassium, dietary recommendations, medication administration and increased dialysis frequency [21]Yes23. A combined approach to abnormal serum bicarbonate includes dialysate dose escalation, oral bicarbonate, nutritional support or individualization of dialysis solution buffer [21]Yes24. Use of unbroken or low molecular weight heparin during HD to reduce arterial-venous clotting [21]Yes25. Prescribing a type of non-heparin anticoagulant in patients with allergy reaction [21]No26. Regular assessment of individual risk in high-risk patients using special devices for further monitoring [21]Yes27. Additional sessions or longer HD time for patients with significant weight gain, high ultrafiltration rate, poor blood pressure control, difficulty achieving dry weight or poor metabolic control (eg, hyperphosphatemia, metabolic acidosis, and/or hyperkalemia) [18]Yes28. Reducing sodium intake in the diet and removing sodium/water by sufficient HD to control blood pressure, hypervolemia and left ventricular hypertrophy [18]Yes29. Changing the central venous catheter (CVC) dressing and using local ointments or solutions inside the catheter (antibiotic and non-antibiotic) to reduce the infection of the catheter exit site and related bacteremia [19]Yes30. Mandatory reporting of viral hepatitis, HIV seroconversion and death during HD in chronic dialysis patients to the Ministry of Health [23]Yes31. Root cause analysis, corrective and preventive protocols of incidents such as: patient fall, medication error, pyogenic reactions, catheter and venous needle displacement [23]YesOutcome measures and quality imperatives in dyalisis 1. Recording the parameters of dialysis treatment in the patients' daily sheet, including: dry weight, blood flow, dialysis solution flow, type and amount of anticoagulant, dialysis duration, dialysis frequency, dialysis filter type, calcium in the dialysis solution and prescribed medicines during dialysis (such as: erythropoietin, intravenous iron) [23]Yes 2. Monitoring of each patient at least once every three months by a nephrologist, including: clinical examination, blood test results and medicines [23]Yes 3. Monitoring HD results at least every three months regarding anemia, nutritional status, dialysis adequacy, and mineral metabolism [23]Yes 4. Adequacy of dialysis: > 95% of patients Kt/V > 1.3 prescribed / > 90% of patients Kt/V > 1.2 delivered Urea Reduction Ratio (URR): > 90% of patients > 65% [20]Somewhat 5. Anemia: Hemoglobin: in > 70% of patients > 10 g/dL; Serum ferritin: in > 90% of patients > 100 ng/ml; Transferrin saturation (TSAT): in > 80% of patients > 20% [20]Somewhat 6. Extracellular fluid management with the aim of removing fluids during HD in order to maintain the optimal weight, volume of the patient and normal blood pressure level [22]Yes 7. Accurate assessment of volume status and dry weight by monthly clinical assessment [21], chest radiography, echocardiographic assessment of inferior vena cava diameter, N-terminal pro-B-typenatriuretic peptide levels, bioelectrical impedance analysis [21], lung ultrasound, etc. [22]Somewhat 8. Optimal serum potassium before HD session in the range of 4.0–6.0 mmol/L and dialysis solution potassium between 1.0 and 3.0 mmol/L (for most patients) [21]No 9. Optimal serum bicarbonate before HD session in the range of 18.0–26.0 mmo/L and dialysis buffer less than or equal to 37.0 mEq/L (for most patients) [21]No Table 1Gap analysis of the current care provision processes for the Iranian HD patients compared to elements of the devised comprehensive package of care for HD patients (CPC-HD)1. Patients' participation in therapeutic decisionsYes/No/Somewhat1. Making the decision to start dialysis jointly by the family and healthcare provider (HCP) about renal replacement therapy (RRT) and several options [17, 18]Yes2. Ultrasound scan or ultrasound before vascular access operation 6 months before starting HD [17]Yes3. Vascular access ways checking in order of preference: arteriovenous fistula (AVF), arterio-venous graft (AVG) and central venous catheter (CVC) [19]Yes4. Training of infection control measures before start of work in HD wards and its annual repetition (topics may include hand washing / taking care of vascular access and detecting signs of infection / administering recommended vaccines) [20]Yes5. Awareness of the risk of dialysis flow interruption, pressure alarm limits and direct observation through an educational program to both physicians and caregivers [21]Somewhat6. Encouraging and empowering patients to actively participate in self-care [17]Somewhat7. Continuous counseling and support of patients and their family members regarding optimal diet and fluid intake [17]Somewhat8. Referring patients to other sources of information and support such as online resources, pre-dialysis classes and peer support groups [17]Somewhat9. Availability of required medicines such as erythropoietin and sevelamer [22]Somewhat10. Appropriate laboratory support for monitoring the effectiveness of HD and early detection of anemia, nutritional status, and infection [22]Somewhat11. Assessment of patient's functional capacity, planned exercise and fall risk reduction strategies [22]No12. Access to exercise facilities with trained staff during dialysis sessions to improve HD patients' quality of life without contraindications [21]No13. Facilitating HD patients' commuting to wards, their economic and activities of daily living (ADL) support [22]Somewhat14. Connecting HD patients to different support networks [22]No15. Identifying those risk factors that may interfere with a successful kidney transplantation such as: non-compliance with treatment, severe mental illness, etc. [17]Somewhat16. Assessment of home hemodialysis possibility [18]No17. Awareness the risks of repeated home HD such as: complications of vascular access and accelerated reduction of residual kidney function [18]No18. Limitations of the HD wards in admitting patients based on the defined personnel and equipment capacity [23]No19. Possibility of financial assistance to low-income patients [23]Somewhat20. Possibility of ensuring access to regular dialysis treatments [23]Somewhat21. Possibility of being responsible against HD patients’ requests to change dialysis schedules in case of problems [23]Yes22. Possibility of timely presence of a physician at the patient's bedside in emergency situations and access to ambulance services [23]Somewhat23. Availability of counseling services for HD treatment, dietary recommendations and medication adherence [23]Yes24. Confidentiality of personal and medical information of HD patients and their accessibility only for designated employees [23]Yes25. Obtaining the patient's informed consent before starting hemodialysis treatment regarding: treatment method, side effects, cost of care, etc. [23]Yes26. Availability of patients’ bill of rights and explanation of their responsibilities, the HD wards' working days/hours timetable (generally six (6) days a week, including official holidays), facilitation of HD patients' transfer to other HD centers based on their request, continuity of care for patients who transfer to other HD centers, establishing a patient complaint system for considering suspected errors and having an official patirnts' informed consent form [23]Yes2. Risk Management and infection control measuresYes/No/Somewhat1. Presence of a strict guideline and its enforcement to prevent the risk of cross-infection among HD patients [20, 24]Somewhat2. Examining patients for HBsAg and anti-HCV before starting the first HD treatment or accepting a patient from another HD center [20] along with checking initial liver function tests [24]Yes3. If HBsAg is negative, retest every three months [20]Yes4. Vaccination of patients if they are HBsAg and HBs Ab negative (four doses sould be administered: zero (0), one (1), two (2) and six (6) months) / if anti HBs Ab < 100 mIU/ml; a booster dose is required [20]Yes5. Examination of anti-HBs Ab serum one to two (1–2) months after completing the vaccination period [20]Yes6. Re-immunization after primary vaccination in patients without anti-HBs Ab response (> 10 mIU/ml) including one to three doses (1–3) [20]Yes7. Examining patients with anti-HBs titer less than 10 every 6 months [24]Yes8. Receiving a course of hepatitis B vaccination according to the national immunization guidelines for non-immune cases of HD patients [22, 24]Yes9. The nurses of HBsAg positive patients should not take care of other patients in the same shift [20]Yes10. Annual screening for blood viruses for HBsAg-negative employees (if anti-HBs antibody is zero, do a full course of vaccination / if anti-HBs antibody is less than 10 mIU/ml a booster dose is required) [20, 24] and re-checking the annual anti-HBs titer [24]Yes11. Receiving HBV vaccine by all dialysis ward staff if there is no proof of previous immunity or previous vaccination [24]Yes12. Refrain to employ a non-immune staff against hepatitis B or those who failed to respond to hepatitis B vaccine for caring HBsAg positive patients [24]Yes13. Training all employees at risk of occupational exposure to blood about hand hygiene, correct use of protective equipments, routes of blood-borne viruses' transmission [20]Yes14. Use of masks and gowns by all nurses and assistants, especially when starting or stopping treatment or blood sampling [22, 24]Somewhat15. Wearing gloves when contacting the dialysis machine and changing it between patients, presence of hand washing and disinfection facilities in several parts of HD wards [22]Yes16. Using gloves, gowns and protective glasses and using a mask/face shield while working to prevent the risk of exposure to blood or other body fluids [24]Somewhat17. Hand hygiene and aseptic technique and its regular observance in HD centers by dialysis staff [24]Yes18. Disinfection of reusable equipment (if disinfection is not possible, such as sphygmomanometer cuff, these devices must be cleaned and dried) [24]Yes19. Allocation of physiological monitoring equipment such as thermometer, barometer and scales for use by each patient [24]No20. Frequent disinfection of touchable places in the patient's environment in HD ward [24]Yes21. Disposing of needles in a metal container (or resistant plastic containers) as safety box using non-contact technique [24]Yes22. Using disposable items and throwing them away after use [24]Yes23. Central venous catheter (CVC), arteriovenous fistula (AVF) and breathing care of all HD patients [23]Yes24. Immunization of HD patients for influenza, pneumococcus and COVID-19 vaccines in addition to hepatitis B vaccine [23]Except pneumococcal vaccinesSomewhat25. Screening of patients before starting HD treatment for viral infections transmitted by blood (hepatitis B, C and HIV) and monitoring according to the national guideline [23]Yes3. Safe Environment, equipments and related productsYes/No/Somewhat1. Sufficient space for the dialysis machine and bed/couch/chair (4.5 m2 to 10 m2 with access to cardiopulmonary resuscitation (CPR) equipment) [20, 22]Somewhat2. A separate room with machines, equipment, tools, disposable items for HBsAg positive patients [20, 22, 24]Yes3. A separate room or an isolated area with a fixed partition and dedicated dialysis machines for patients with active hepatitis C [20, 24] No4. A separate room with machines, equipment, tools, disposable items for HIV-positive patients [20, 24]No5. A separate room for water purification of the necessary size and equipment [20, 22, 23] with the schematic diagram of water purification system [23]Somewhat6. A dialysis filter reprocessing room in case of reuse of filters and re-storage of processed and sterilized filters with proper and efficient ventilation to reduce the risk of inhalation [20, 22]No7. A separate room with a separate filter reprocessing machine to reprocess the filters of hepatitis B and hepatitis C patients separately [12, 14]No8. Releasing of dialysis and reprocessing effluent to the closed general drainage system / not using formaldehyde in case of discharging the effluent to a septic tank and having sufficient capacity of the tank to manage the volume of effluent [20]Somewhat9. Access to a stable electrical source as well as oxygen and suction outlets in each ward [22]Yes10. A list of items in the CPR trolley and its review at regular intervals [23]Yes11. Management and monitoring of cold chain storage for medicinal products [23]YesEquipment 1. Ability to perform conventional HD (diffusion) and preferably convection treatment in HD devices [20, 22]Yes 2. Providing a reliable power source (to ensure returning blood from the arterial-venous lines to the body in case of a power cut) [20, 22]Yes 3. At least one backup device for every ten (10) HD machines [20]No 4. Disinfection of external surfaces of HD devices after each session [20, 22]Somewhat 5. Disinfection of the internal hydraulic circuit of HD machines after the last daily session [20, 22]Yes 6. Having Planned Preventive Maintenance (PPM) and technical safety check for all machines and documentation [20]Yes 7. Possibility of continuous renal replacement therapy (CRRT) in all wards as part of a comprehensive program of RRT [21]SomewhatDialysis consumables 1. Request of a valid quality certificate for all commercial dialysis solution [20, 22]Yes 2. Validation of filters used for HD treatment [20, 22]Yes 3.Request of a valid quality certificate for the arterial-venous sets that are used for HD treatment and taking all precautionary measures for prevention of their reuse [20, 22]Yes 4. Request of a valid quality approval for arterial-venous needles that are used during HD treatment [20, 22]Yes 5. Disposal of clinical waste according to the current instructions of the Ministry of Health and Medical Education (MOHME) [20] (refrigerated storage in case of daily collection at 4–6 degree of celsius and daily recording of the room temperature) [23]YesWater quality 1. Daily chlorine/chloramine test and hardness test every morning before starting HD treatment [20]No 2. Perform monthly tests for bacterial and endotoxin pollutions [20, 22]Yes 3. Production of dialysis water by reverse osmosis (RO) process [20]Yes 4. Six months test in an accredited laboratory to analyze and check chemical compounds of the water are used [20]Yes4. Workforce and human resources managementYes/No/Somewhat1. Assigning the role of dialysis department head to a nephrologist or a general physician with at least 200 h of formal training in HD treatment [20–22]Somewhat2. Recruit nurses/medical assistants with at least six (6) months of training and experience in the field of HD [20–22] with valid annual practicing certificate (APC) [23]Somewhat3. Recruit head-nurses with a basic degree in renal nursing and valid APC with at least two years of work experience in the HD department [23]Somewhat4. The presence of at least one nurse/medical assistant with at least six months training of HD treatment for every six HD patients [20]Somewhat5. The presence of at least one nurse/medical assistant trained in CPR techniques in each shift [20]Yes6. Performing HD according to the order of a nephrologist or a general physician with the necessary training under the supervision of a nephrologist [20]Yes7. HD treatment and care by a nurse or medical assistant with training and experience in the field of HD treatment and care [20]Yes8. Availability of trained technicians to repair HD machines [21, 22]No9. The presence of social workers and nutritionists in the HD ward [22]No10. Monitor all proceedings of prevention and infection control processes at the facility by a designated and trained nurse and document catheter-related bloodstream infections (CRBSIs), fistula infections, blood-borne viral and bacterial infections, and COVID-19 infections [23]Yes5. Care Effectiveness and monitoring of HD patients' improvementYes/No/Somewhat1. Start HD if uremic symptoms affect daily life, biochemical values, uncontrollable fluid overload or estimated glomerular filtration rate (eGFR) of about 5 to 7 ml/min/1.73 m2 [17, 18]Yes2. Recording each session and monitoring any complication during HD (nausea, vomiting and headache / hypotension or hypertension / pyrogenic reaction: shivering, convulsions, fever during dialysis / hemolysis / acute blood loss / air embolism / mental status change / signs and symptoms of first HD syndrome including: chest pain, anxiety, shortness of breath and back pain), vital signs during dialysis, vascular access [20] and informing the patient about all these risks before the start of treatment [18]Yes3. Staff training in dealing with emergencies during HD including: acute hypotension, blood loss, hemolysis, air embolism, dialysis membrane reactions, high fever, sepsis and cardiovascular emergencies and their management [21, 22]Yes4. Appropriate protocols to monitor complications such as: patency and infections in AVF and AVGs [22]Somewhat5. Blood tests should be done regularly at intervals of three months or moreYes6. Checking the adequacy of dialysis at least every three months (Kt/V more than 1.2 or urea reduction ratio (URR) more than 65%) [15, 19, 20]Yes7. Focus on preserving residual kidney function by emphasizing strategies to reduce the rate and frequency of hypotensive attacks during HD, applying slower ultrafiltration rates, encouraging a low-sodium diet, avoiding unnecessary use of nephrotoxic medicines (such as aminoglycosides and radiocontrast) and prevention of infection [22]Yes8. Evaluation of protein and energy status by nutritionists (prevalence of malnutrition problem is high in most HD patients due to insufficiency of HD, underlying inflammation and undiagnosed infections) [17, 22]No9. Having a quality improvement program for achieving objectives of the standard care, including management of high blood pressure, fluid overload, infections, and reporting physical findings [22]No10. Perform HD at least 12 h per week for most patients (3 times per week) with minimal residual function [18, 21]Yes11. Using filters with artificial or cellulose membranes to prevent blood pressure drop during HD with symptoms [25]Yes12. Using high-flux filters for patients with minimal residual function and removal of molecules such as microglobulin beta 2 [21, 25]Yes13. Considering the benefits of high-flux filters for the survival of diabetic patients, patients with HD history of more than 3.7 years and serum albumin less than 40 g/L [25]Yes14. Use of high-flux or low-flux filters (biocompatible) for intermittent HD [18]Yes15. Proposing hemodiafiltration as a treatment for resistant hypotensive patients in comparison to HD patients with good prognosis [21]No16. Washing HD lines and filters to lose minimal blood [21]Yes17. Fluid and volume control in HD patients through salt restriction, use of diuretics and antihypertensive medicines [22]Yes18. Starting erythropoietic stimulating agents to reach a hemoglobin level of 9 to 10 g/dL [22]Yes19. Treatment of mineral and bone disorders to reduce phosphorus serum level, diet counseling and prescription of medicines (such as Sevelamer with lower rate of mortality compared to calcium-based binders) to reduce phosphorus absorption from the gastrointestinal tract [22]Yes20. Parathyroid Hormone (PTH) lowering treatment with medicines: calcimimetics, calcitriol or vitamin D analogs [22]Yes21. Avoiding excessive ultrafiltration in case of fluid overload by using an additional schedule and adjusting the dialysis temperature [21]Yes22. Management of hyperkalemia through: reducing dialysis solution potassium, dietary recommendations, medication administration and increased dialysis frequency [21]Yes23. A combined approach to abnormal serum bicarbonate includes dialysate dose escalation, oral bicarbonate, nutritional support or individualization of dialysis solution buffer [21]Yes24. Use of unbroken or low molecular weight heparin during HD to reduce arterial-venous clotting [21]Yes25. Prescribing a type of non-heparin anticoagulant in patients with allergy reaction [21]No26. Regular assessment of individual risk in high-risk patients using special devices for further monitoring [21]Yes27. Additional sessions or longer HD time for patients with significant weight gain, high ultrafiltration rate, poor blood pressure control, difficulty achieving dry weight or poor metabolic control (eg, hyperphosphatemia, metabolic acidosis, and/or hyperkalemia) [18]Yes28. Reducing sodium intake in the diet and removing sodium/water by sufficient HD to control blood pressure, hypervolemia and left ventricular hypertrophy [18]Yes29. Changing the central venous catheter (CVC) dressing and using local ointments or solutions inside the catheter (antibiotic and non-antibiotic) to reduce the infection of the catheter exit site and related bacteremia [19]Yes30. Mandatory reporting of viral hepatitis, HIV seroconversion and death during HD in chronic dialysis patients to the Ministry of Health [23]Yes31. Root cause analysis, corrective and preventive protocols of incidents such as: patient fall, medication error, pyogenic reactions, catheter and venous needle displacement [23]YesOutcome measures and quality imperatives in dyalisis 1. Recording the parameters of dialysis treatment in the patients' daily sheet, including: dry weight, blood flow, dialysis solution flow, type and amount of anticoagulant, dialysis duration, dialysis frequency, dialysis filter type, calcium in the dialysis solution and prescribed medicines during dialysis (such as: erythropoietin, intravenous iron) [23]Yes 2. Monitoring of each patient at least once every three months by a nephrologist, including: clinical examination, blood test results and medicines [23]Yes 3. Monitoring HD results at least every three months regarding anemia, nutritional status, dialysis adequacy, and mineral metabolism [23]Yes 4. Adequacy of dialysis: > 95% of patients Kt/V > 1.3 prescribed / > 90% of patients Kt/V > 1.2 delivered Urea Reduction Ratio (URR): > 90% of patients > 65% [20]Somewhat 5. Anemia: Hemoglobin: in > 70% of patients > 10 g/dL; Serum ferritin: in > 90% of patients > 100 ng/ml; Transferrin saturation (TSAT): in > 80% of patients > 20% [20]Somewhat 6. Extracellular fluid management with the aim of removing fluids during HD in order to maintain the optimal weight, volume of the patient and normal blood pressure level [22]Yes 7. Accurate assessment of volume status and dry weight by monthly clinical assessment [21], chest radiography, echocardiographic assessment of inferior vena cava diameter, N-terminal pro-B-typenatriuretic peptide levels, bioelectrical impedance analysis [21], lung ultrasound, etc. [22]Somewhat 8. Optimal serum potassium before HD session in the range of 4.0–6.0 mmol/L and dialysis solution potassium between 1.0 and 3.0 mmol/L (for most patients) [21]No 9. Optimal serum bicarbonate before HD session in the range of 18.0–26.0 mmo/L and dialysis buffer less than or equal to 37.0 mEq/L (for most patients) [21]No Gap analysis of the current care provision processes for the Iranian HD patients compared to elements of the devised comprehensive package of care for HD patients (CPC-HD) 24. Immunization of HD patients for influenza, pneumococcus and COVID-19 vaccines in addition to hepatitis B vaccine [23] Except pneumococcal vaccines 4. Adequacy of dialysis: > 95% of patients Kt/V > 1.3 prescribed / > 90% of patients Kt/V > 1.2 delivered Urea Reduction Ratio (URR): > 90% of patients > 65% [20] As tabulated main shortages in the category of “supply of resources, medical devices and equipment support” were inadequacy of the physical space and devices relative to the number of patients, lack or limitation of physical space for isolation of HCV (hepatitis C virus) and HIV (human immunodeficiency virus) positive patients and fixed backup device, lack of adequate insurance coverage for all medication and pharmaceutical items, lack of a comprehensive financial/non-financial support and illness benefit scheme, shortage or lack of necessary equipment to be used during dialysis, home HD or kidney transplantation. Important identified deficits relating to the “recruitment and endorsement of clinics and general work force” aspect included lack of a devised program or not implementing of the mandatory 6-month probationary training course for nurses before their start of work in the HD wards, lack of professional dialysis nutritionists for recruitment to work in HD wards, shortage of HD machine technicians, and psychologists or psychiatrists to assess patients’ mental health regularly and shortage of social workers to support HD patients through a comprehensive network of social support services (that include peer and volunteer groups’ support or funds and facilities provided by certain non-governmental charities and organizations) to help vulnerable and disadvantaged HD patients. Main pinpointed inadequacies in the “infection prevention and controlling procedures” and “provision of safe environment for both HD patients and hospitals’ staff” aspects comprised lack of a continuous monitoring program and strict precautionary measures regarding the use of personal protective equipment, low level of pneumococcal vaccine coverage among the patients and staffs and not performing routine nasal culture for identification of positive staphylococcus cases. Consequential identified shortcomings related to the “monitoring of care effectiveness and quality improvement” aspect of HD services in the Iranian hospitals were lack of a robust protocol for assessment of protein-energy intake adequacy, not having a programmed screening and monitoring procedures to ensure achieving of Kt/V > 1.2 goal (measure of dialysis adequacy) in 90% of the patients, lack of accurate dry weight assessment tools, hemodiafiltration program and vascular access monitoring. Discussion Main aim of this study was to identify gaps in provision of ESRD care to HD patients in Iran based on a comparative analysis and benchmarking approach. The HD patients in Iran as a transitional LMIC do not receive the quality care they are deserving due to several organizational deficits including lack of updated and evidence–informed HD care protocol [12–14]. The study findings revealed considerable unmet needs of the Iranian HD patients in terms of the required resources supply, medical devices and equipment support, work force recruitment and endorsement, infection prevention and controlling procedures, care effectiveness and quality improvement monitoring and provision of safe environment for both HD patients and hospitals’ staff. These deficits herald the widening gap in the organizational knowledge and pefomance balance that is needed to narrow down since it fuels the current disenchantment among the both HCPs and HD patients. Similar unmet needs of HD patients were reported from both developed and developing countries of the world [19–23]. Several infrastructural limitaions including shortage of manpower and financial resources have been reported as the main antecedents of substandard HD services in LMICs [24–26] however, critical role of political commitment and leadership embeddedness in enhancing organizational performance should not be underestimated. Difficulties in recruitment of well-trained and proficient nursing staff to provide care for HD patients and building a sympathetic and caring partnership with each patient was pinpointed in this study. Such a restrain is a global phenomenon [19–23, 27] and can be associated with the nurses workload and their burnout in the HD units. But limited organizational positions and budgetary resources for hiring and keeping qualified and competent nursing staff from one hand and inability of the INHS in delination of an internationally acceptable and logical wage and salary for nursing staff in the HD units have aggrevated the problem in Iran. Such an inadequacy reveals its impacts on the HD patients’ overall wellbeing, quality of life, CKD related complications or mortality. The amount of direct and indirect out-of-pocket payments that HD patients in Iran should make for use of HD services specially in the lower socioecomic gradients might not be bearable. Owing to a high consistent inflation rate in the country [28] which may cause an extra burden on the patients’ economy and quality of life, a higher level of social responsiveness and commitment to healthcare quality and excellence is required in the INHS. A balancing strategy to curb out-of-pocket payment by the HD patients in Iran could have positive consequences beyond merely financial circumstances of the patients and directly affects their accessibility and use of mostly required life-saving HD services. To sum up, the basic challenges in providing quality care for HDs in Iran compared with an evidence-informed presumptive care delivery guideline can be classified in the following four dimensions.1. Insufficient physical space and medical equipments: Atleast a physical space of 4.5 m2 per patient equiped with cardiopulomonary resaciation facilities (CPR) was recommended for provosion of qulaity HD care for the patients [17, 18]. But securing such a space with the mentioned facilities in LMICs including Iran for HD units requires added investments in supply-chain and logistics that seems to be unachievalble in short term. The current limited physical space and shortage of medical equipments resulted to overcrowding of the HD units in Iran and a lower care quality for the HD patients. Another challenge is related to the current in use HD machines that are from different brands and producers therefore, maintaing their spare parts and monthly services is demanding.2. Inadequacies of infection prevention and control measures: Infected patients with HCV or HIV are recommended to be dialyzed according to the endorsed protocol for infected pateints with hepatit B virus i.e. connection to separate and dedicated HD machines to prevent cross-infection [17, 27]. This is while, according to the Iranian NASGH [16], isolation of infected patients with HCV or HIV is unnecessary in HD units.3. Availability and capability of purchasing the required medication: Paying for costs of the essential medicines such as Sevelamer and Erythropoietin which are relatively expensive was another pinpointed problem with potential to pose an extra burden on HD patients in LMICs [29]. HD patients in Iran have different health insurance coverages with diverse policies in reimbursing medications cost. Inability of the HD patients in payment of full or partial prices of their required medications for a successful HD treatment is one of the main reasons for medication nonadherence among the HD patients [30].HD patients are generally require help in commuting to the dialysis center, performing their daily life activities and payment of ordinary living costs due to variety of reasons including lossing job or their illness-related reduction of income [18]. Such a need for financial support among HD patients is not limited to the LMICs but it is also reported from upper income countries (UICs) of the world [3, 31, 32]. Providing opportunities for HD patients to work from home or finding a prefered home job are strtaegies that can be liaised or advocated through social work partenerships [33]. A mix of financial and other non-fiscal supports can be obtained by the HD patients in Iran from a number of charities, NGOs and government run organizations e.g. Iranian Welfare Organizations (IWO) or Ministry of Cooperatives, Labour, and Social Welfare (MoCLSW). But these supports are generally not sufficient to cover all of the disease-related or general life expenses of the HD patients.Functional capabilites of the HD patients due to physical weakness and reduced exersice capacities are diminished therefore, the risk of falling and fractures increases. Provision of excersice facilities for HD patients to do exertion under supervision of trained staff is recommended and needed measure [24]. There are ample amount of evidence that indicated a combination of aerobic and resistance exercise may pose significant improvement on HD patients’ depression symptoms and QOL [34, 35]. Despite the benefits of performing regenerating and recreational exercise acitivities on overall wellbeing and prevention of a number of certain life threatening complications in HD patients no advice or recommendation nor a detailed guideline for preparation of facilities for HD patients’ regular execise were given in the current NASGH [16].4. Recruitment and endorsement of clinics and general work forceRecruitment and presence of specialist workforce in HD units that should include nephrologists, trained staff, technicines, social workers, nutritionists, psychologists and psychiatrists is a basic requisite to provide quality care for the patients and maintain their safety [17, 18, 36]. Shortage of professional staff in HD units inevitably could pose as a major obstacle in care provision. Difficluties in recruitment and maintaining the required number of professional staff to work in HD units and their contionous training for providing desired quality care to HD patients is another pinpointed organizational challenge in Iran that need to be addressed [32]. Lack of a trained resident technician to check the performance of reverse osmosis (RO) and fix the defects of HD machines [17], a dialysis nutritionist to check the protein-energy status and support the patients with information about dietary restrictions and liquid consumption are examples of the workforce inadquacies in the INHS.Preparation and provision of informational materials to HD patients or scheduling peer support opportunities to empower patients and attract their full participation and cooperation in HD sessions was indicated to increase possibility of HD success rate [18, 26]. Despite being emphasized in the literature and the MOHME’s policy documents, no regular and coherent program to prepare useful e-educational contents, pre-dialysis education, training of the HD patients’ companions, building of peer support groups, or other empowerment activities are in place to boost HD success rate and decrease failures or HD-related complications. Routine examination of mental health status is not performed for all HD patients and only those with depressive symptoms are visited by physchatrists. This might hamper efforts of other medical staff in provision of successful healthcare and boosting QOL among the HD patients.Prevention of cross-contamination in HD units is a major endeavor for working staff with remarkable impact on HD patients’ safety while being dialysed. All HD centers should have strict measures to prevent the risk of cross-infection among HD patients [31]. It is recommended that nurses and all assistants should wear masks, gowns, gloves and protective glasses when dealing with patients, especially when starting or stopping treatment [29, 32]. Despite the national and international directives, the protective equipment application is not fully complied with in the country due to the lack of strict supervision, regular monitoring and unavailability of the protective appliances.Immunization of HD patients is recommended for influenza, pneumococcal and COVID-19 in addition to hepatitis B [33]. Based on the accreditation document, all required vaccines except pneumococcal vaccine (due to financial burden) are provided to the Iranian HD patients.5. Monitoring of the effectiveness and improving the quality of care for HD patients: Adequacy of dialysis is evaluated through clinical assessment of general health, fluid status, and control of laboratory parameters, along with determination of dialysis dose [34]. Therefore, at least 90% of patients (three times a week) should have minimum Kt/V > 1.2 or URR > 65% (urea reduction ratio) [31, 34, 35]. Control of laboratory parameters is carried out on a monthly basis. Inadequate protein consumption, insufficient education about nutritional restrictions, defects of HD machines and cardiovascular diseases are the main identified causes of dialysis inadequacies among most of the patients. 1. Insufficient physical space and medical equipments: Atleast a physical space of 4.5 m2 per patient equiped with cardiopulomonary resaciation facilities (CPR) was recommended for provosion of qulaity HD care for the patients [17, 18]. But securing such a space with the mentioned facilities in LMICs including Iran for HD units requires added investments in supply-chain and logistics that seems to be unachievalble in short term. The current limited physical space and shortage of medical equipments resulted to overcrowding of the HD units in Iran and a lower care quality for the HD patients. Another challenge is related to the current in use HD machines that are from different brands and producers therefore, maintaing their spare parts and monthly services is demanding. 1. Insufficient physical space and medical equipments: Atleast a physical space of 4.5 m2 per patient equiped with cardiopulomonary resaciation facilities (CPR) was recommended for provosion of qulaity HD care for the patients [17, 18]. But securing such a space with the mentioned facilities in LMICs including Iran for HD units requires added investments in supply-chain and logistics that seems to be unachievalble in short term. The current limited physical space and shortage of medical equipments resulted to overcrowding of the HD units in Iran and a lower care quality for the HD patients. Another challenge is related to the current in use HD machines that are from different brands and producers therefore, maintaing their spare parts and monthly services is demanding. 2. Inadequacies of infection prevention and control measures: Infected patients with HCV or HIV are recommended to be dialyzed according to the endorsed protocol for infected pateints with hepatit B virus i.e. connection to separate and dedicated HD machines to prevent cross-infection [17, 27]. This is while, according to the Iranian NASGH [16], isolation of infected patients with HCV or HIV is unnecessary in HD units. 2. Inadequacies of infection prevention and control measures: Infected patients with HCV or HIV are recommended to be dialyzed according to the endorsed protocol for infected pateints with hepatit B virus i.e. connection to separate and dedicated HD machines to prevent cross-infection [17, 27]. This is while, according to the Iranian NASGH [16], isolation of infected patients with HCV or HIV is unnecessary in HD units. 3. Availability and capability of purchasing the required medication: Paying for costs of the essential medicines such as Sevelamer and Erythropoietin which are relatively expensive was another pinpointed problem with potential to pose an extra burden on HD patients in LMICs [29]. HD patients in Iran have different health insurance coverages with diverse policies in reimbursing medications cost. Inability of the HD patients in payment of full or partial prices of their required medications for a successful HD treatment is one of the main reasons for medication nonadherence among the HD patients [30]. 3. Availability and capability of purchasing the required medication: Paying for costs of the essential medicines such as Sevelamer and Erythropoietin which are relatively expensive was another pinpointed problem with potential to pose an extra burden on HD patients in LMICs [29]. HD patients in Iran have different health insurance coverages with diverse policies in reimbursing medications cost. Inability of the HD patients in payment of full or partial prices of their required medications for a successful HD treatment is one of the main reasons for medication nonadherence among the HD patients [30]. HD patients are generally require help in commuting to the dialysis center, performing their daily life activities and payment of ordinary living costs due to variety of reasons including lossing job or their illness-related reduction of income [18]. Such a need for financial support among HD patients is not limited to the LMICs but it is also reported from upper income countries (UICs) of the world [3, 31, 32]. Providing opportunities for HD patients to work from home or finding a prefered home job are strtaegies that can be liaised or advocated through social work partenerships [33]. A mix of financial and other non-fiscal supports can be obtained by the HD patients in Iran from a number of charities, NGOs and government run organizations e.g. Iranian Welfare Organizations (IWO) or Ministry of Cooperatives, Labour, and Social Welfare (MoCLSW). But these supports are generally not sufficient to cover all of the disease-related or general life expenses of the HD patients. HD patients are generally require help in commuting to the dialysis center, performing their daily life activities and payment of ordinary living costs due to variety of reasons including lossing job or their illness-related reduction of income [18]. Such a need for financial support among HD patients is not limited to the LMICs but it is also reported from upper income countries (UICs) of the world [3, 31, 32]. Providing opportunities for HD patients to work from home or finding a prefered home job are strtaegies that can be liaised or advocated through social work partenerships [33]. A mix of financial and other non-fiscal supports can be obtained by the HD patients in Iran from a number of charities, NGOs and government run organizations e.g. Iranian Welfare Organizations (IWO) or Ministry of Cooperatives, Labour, and Social Welfare (MoCLSW). But these supports are generally not sufficient to cover all of the disease-related or general life expenses of the HD patients. Functional capabilites of the HD patients due to physical weakness and reduced exersice capacities are diminished therefore, the risk of falling and fractures increases. Provision of excersice facilities for HD patients to do exertion under supervision of trained staff is recommended and needed measure [24]. There are ample amount of evidence that indicated a combination of aerobic and resistance exercise may pose significant improvement on HD patients’ depression symptoms and QOL [34, 35]. Despite the benefits of performing regenerating and recreational exercise acitivities on overall wellbeing and prevention of a number of certain life threatening complications in HD patients no advice or recommendation nor a detailed guideline for preparation of facilities for HD patients’ regular execise were given in the current NASGH [16]. Functional capabilites of the HD patients due to physical weakness and reduced exersice capacities are diminished therefore, the risk of falling and fractures increases. Provision of excersice facilities for HD patients to do exertion under supervision of trained staff is recommended and needed measure [24]. There are ample amount of evidence that indicated a combination of aerobic and resistance exercise may pose significant improvement on HD patients’ depression symptoms and QOL [34, 35]. Despite the benefits of performing regenerating and recreational exercise acitivities on overall wellbeing and prevention of a number of certain life threatening complications in HD patients no advice or recommendation nor a detailed guideline for preparation of facilities for HD patients’ regular execise were given in the current NASGH [16]. 4. Recruitment and endorsement of clinics and general work force 4. Recruitment and endorsement of clinics and general work force Recruitment and presence of specialist workforce in HD units that should include nephrologists, trained staff, technicines, social workers, nutritionists, psychologists and psychiatrists is a basic requisite to provide quality care for the patients and maintain their safety [17, 18, 36]. Shortage of professional staff in HD units inevitably could pose as a major obstacle in care provision. Difficluties in recruitment and maintaining the required number of professional staff to work in HD units and their contionous training for providing desired quality care to HD patients is another pinpointed organizational challenge in Iran that need to be addressed [32]. Lack of a trained resident technician to check the performance of reverse osmosis (RO) and fix the defects of HD machines [17], a dialysis nutritionist to check the protein-energy status and support the patients with information about dietary restrictions and liquid consumption are examples of the workforce inadquacies in the INHS. Recruitment and presence of specialist workforce in HD units that should include nephrologists, trained staff, technicines, social workers, nutritionists, psychologists and psychiatrists is a basic requisite to provide quality care for the patients and maintain their safety [17, 18, 36]. Shortage of professional staff in HD units inevitably could pose as a major obstacle in care provision. Difficluties in recruitment and maintaining the required number of professional staff to work in HD units and their contionous training for providing desired quality care to HD patients is another pinpointed organizational challenge in Iran that need to be addressed [32]. Lack of a trained resident technician to check the performance of reverse osmosis (RO) and fix the defects of HD machines [17], a dialysis nutritionist to check the protein-energy status and support the patients with information about dietary restrictions and liquid consumption are examples of the workforce inadquacies in the INHS. Preparation and provision of informational materials to HD patients or scheduling peer support opportunities to empower patients and attract their full participation and cooperation in HD sessions was indicated to increase possibility of HD success rate [18, 26]. Despite being emphasized in the literature and the MOHME’s policy documents, no regular and coherent program to prepare useful e-educational contents, pre-dialysis education, training of the HD patients’ companions, building of peer support groups, or other empowerment activities are in place to boost HD success rate and decrease failures or HD-related complications. Routine examination of mental health status is not performed for all HD patients and only those with depressive symptoms are visited by physchatrists. This might hamper efforts of other medical staff in provision of successful healthcare and boosting QOL among the HD patients. Preparation and provision of informational materials to HD patients or scheduling peer support opportunities to empower patients and attract their full participation and cooperation in HD sessions was indicated to increase possibility of HD success rate [18, 26]. Despite being emphasized in the literature and the MOHME’s policy documents, no regular and coherent program to prepare useful e-educational contents, pre-dialysis education, training of the HD patients’ companions, building of peer support groups, or other empowerment activities are in place to boost HD success rate and decrease failures or HD-related complications. Routine examination of mental health status is not performed for all HD patients and only those with depressive symptoms are visited by physchatrists. This might hamper efforts of other medical staff in provision of successful healthcare and boosting QOL among the HD patients. Prevention of cross-contamination in HD units is a major endeavor for working staff with remarkable impact on HD patients’ safety while being dialysed. All HD centers should have strict measures to prevent the risk of cross-infection among HD patients [31]. It is recommended that nurses and all assistants should wear masks, gowns, gloves and protective glasses when dealing with patients, especially when starting or stopping treatment [29, 32]. Despite the national and international directives, the protective equipment application is not fully complied with in the country due to the lack of strict supervision, regular monitoring and unavailability of the protective appliances. Prevention of cross-contamination in HD units is a major endeavor for working staff with remarkable impact on HD patients’ safety while being dialysed. All HD centers should have strict measures to prevent the risk of cross-infection among HD patients [31]. It is recommended that nurses and all assistants should wear masks, gowns, gloves and protective glasses when dealing with patients, especially when starting or stopping treatment [29, 32]. Despite the national and international directives, the protective equipment application is not fully complied with in the country due to the lack of strict supervision, regular monitoring and unavailability of the protective appliances. Immunization of HD patients is recommended for influenza, pneumococcal and COVID-19 in addition to hepatitis B [33]. Based on the accreditation document, all required vaccines except pneumococcal vaccine (due to financial burden) are provided to the Iranian HD patients. Immunization of HD patients is recommended for influenza, pneumococcal and COVID-19 in addition to hepatitis B [33]. Based on the accreditation document, all required vaccines except pneumococcal vaccine (due to financial burden) are provided to the Iranian HD patients. 5. Monitoring of the effectiveness and improving the quality of care for HD patients: Adequacy of dialysis is evaluated through clinical assessment of general health, fluid status, and control of laboratory parameters, along with determination of dialysis dose [34]. Therefore, at least 90% of patients (three times a week) should have minimum Kt/V > 1.2 or URR > 65% (urea reduction ratio) [31, 34, 35]. Control of laboratory parameters is carried out on a monthly basis. Inadequate protein consumption, insufficient education about nutritional restrictions, defects of HD machines and cardiovascular diseases are the main identified causes of dialysis inadequacies among most of the patients. 5. Monitoring of the effectiveness and improving the quality of care for HD patients: Adequacy of dialysis is evaluated through clinical assessment of general health, fluid status, and control of laboratory parameters, along with determination of dialysis dose [34]. Therefore, at least 90% of patients (three times a week) should have minimum Kt/V > 1.2 or URR > 65% (urea reduction ratio) [31, 34, 35]. Control of laboratory parameters is carried out on a monthly basis. Inadequate protein consumption, insufficient education about nutritional restrictions, defects of HD machines and cardiovascular diseases are the main identified causes of dialysis inadequacies among most of the patients. Evaluation of fluid status was recommended to be predicted by determining clinical dry weight through monthly based clinical evaluation of fluid status, chest radiography, bioelectrical impedance assessment at regular intervals, lung ultrasound, etc. These tools may not be available in LMICs [29, 34, 36]. Barriers to use bio-impedance are insufficient validity, lack of awareness, insufficient knowledge, limited self-efficacy, lack of required infrastructure and contradictory regulations. Factors such as the device's attractiveness and users’ experiences of its benefits in practice were reported to facilitate its use [36]. In Iran, due to the lack of access to specialized equipment (bio-impedance analysis machine), the evaluation of fluid status is generally based on the once a month clinical evaluation (blood pressure measurement, respiratory status, and weighing before and after dialysis) and per annum echocardiography. Several Studies recommended cognitive-behavioral strategies to promote adherence to the food/fluid diet based on the evaluation of biological and clinical indicators [14, 37]. The main reasons for the non-adherence of HD patients in Iran are inadequate social support in all dimensions and lack of a regular schedule for mental health screening. A quality improvement program is required to endorse standard care provision to HD patients, including control of hypertension, fluid overload, infections, management of anemia, metabolic parameters, and full documenting of the physical findings [29]. These inadequacies in the INHS were addressed and reported by the approached nephrologists and nurses, but there is no targeted program and a standard protocol in the system to improve HD quality. Transplantation for adults should be considered if risk factors such as: lack of social support, treatment nonadherence, severe mental illness, substance abuse with severe dependency with poor outcomes are identified [38]. The high cost of transplantation and the preparation of immunosuppressive medicines after transplantation are the main challenges for the patients in the country. Limitations This evidence-informed gap analysis has main methodological limitations. First, because of the heterogeneity of the included studies with regard to their stated aims, the research team preferred to give an augmented summary of findings. Second, despite efforts were made to identify all relevant publications possibility of selection bias should not be ruled out completely. Third, the one-sided analysis of the reported de facto conditions of healthcare delivery to HD patients by the recruited experts and recommended elements of practices in NASGH [16] has potential to cast shadow on real world circumstances and experiences of HD patients since opinions of the patients were not examined in this study. Last, based on the employed qualitative approach for the data analysis no attempt was made to examine quantitaitve differences between the devised CPC-HD’s elements and the current provided care components. Despite the mentioned limitations, the findings could provide a promising evidence base to be used for transformation of the current care practices that are offered to HD patients in Iran. Planning a qualitative reseach in future to understand major challenges and barriers of revising the current care protocol for HD patients in Iran throuth the key policymakers’ point of views and most importantly exploring the sollutions that might be applicable to tackle the shortcomings in the INHS could have added value for correctional interventions. Suggestions Sound strategies and policies are needed in the country to respond unmet healthcare needs of the HD patients that reside in different geographical locations (rural/urban) and provinces as a part of social justice endeavor that is recommended by the WHO [39]. The discussed caveats in the Iranian hospitals’ HD wards are currently infuriating due to surge of healthcare professionals’ migration from the country [40, 41] that posed extra burden on the shoulders of the country’s healthcare policy makers. Healthcare professionals’ migration from LMICs is a global phenomenon [42] but needs to be especially addressed in Iran because of a consistent high inflation rate [43, 44] with considerable impact on their quality of life. With the current pattern of experienced health professionals’ depletion from the INHS worsening of the provided care quality to HDs is anticipated in near future. However, in short term the gap analysis outputs could be used to justify prioritization of measures that are applicable for improving HD patients care quality in Iran.